| |
| |
|
| Insider
Information: |
Baddour Linda |
| Relationship: |
Director |
| City: |
Wilmington |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
56,728 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,130,669 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
56,728 |
|
|
| Total
Value |
$1,130,669 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -17.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmaceutical Product Developme... |
PPDI |
Chief Financial Officer |
2007-06-01 |
19,943 |
2005-05-05 |
0 |
Premium* |
|
|
Pra Health Sciences, Inc. |
PRAH |
Executive VP & CFO |
2018-01-16 |
0 |
2016-03-02 |
0 |
Premium* |
|
|
Waters Corp |
WAT |
Director |
2024-03-13 |
2,250 |
2018-09-04 |
0 |
Premium* |
|
|
Cryoport Inc |
CYRX |
Director |
2024-05-17 |
34,535 |
2021-04-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRAH |
Pra Health Sciences, Inc. |
Executive VP & CFO |
• – – |
2017-04-17 |
4 |
AS |
$63.59 |
$12,488,631 |
D/D |
(196,393) |
0 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Executive VP & CFO |
• – – |
2017-08-14 |
4 |
S |
$74.85 |
$7,485,000 |
D/D |
(100,000) |
0 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Executive VP & CFO |
• – – |
2018-01-16 |
4 |
AS |
$90.26 |
$6,048,199 |
D/D |
(67,000) |
0 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Executive VP & CFO |
• – – |
2016-05-06 |
4 |
S |
$46.70 |
$4,310,784 |
D/D |
(92,308) |
0 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Executive VP & CFO |
• – – |
2016-03-08 |
4 |
S |
$42.26 |
$3,930,180 |
D/D |
(93,000) |
0 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Executive VP & CFO |
• – – |
2016-08-15 |
4 |
AS |
$52.00 |
$3,607,760 |
D/D |
(69,380) |
0 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Chief Financial Officer |
• – – |
2007-02-09 |
4 |
S |
$33.87 |
$2,143,505 |
D/D |
(63,000) |
58,733 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Chief Financial Officer |
• – – |
2006-11-10 |
4 |
S |
$31.61 |
$1,761,784 |
D/D |
(55,479) |
49,233 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Chief Financial Officer |
• – – |
2007-05-03 |
4 |
S |
$34.90 |
$1,466,400 |
D/D |
(41,982) |
28,000 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Chief Financial Officer |
• – – |
2007-02-09 |
4 |
OE |
$15.30 |
$1,400,700 |
D/D |
80,000 |
121,733 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Executive VP & CFO |
• – – |
2017-04-17 |
4 |
OE |
$2.94 |
$1,209,581 |
D/D |
196,393 |
71,921 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Executive VP & CFO |
• – – |
2017-08-08 |
4 |
OE |
$11.73 |
$1,173,000 |
D/D |
100,000 |
100,000 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Chief Financial Officer |
• – – |
2006-02-24 |
4 |
S |
$69.62 |
$1,044,951 |
D/D |
(15,000) |
23,590 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
Chief Financial Officer |
• – – |
2006-11-10 |
4 |
OE |
$11.98 |
$865,288 |
D/D |
62,979 |
104,712 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Chief Financial Officer |
• – – |
2005-05-05 |
4 |
S |
$47.51 |
$831,425 |
D/D |
(17,500) |
2,590 |
|
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Executive VP & CFO |
• – – |
2018-01-16 |
4 |
OE |
$11.73 |
$785,910 |
D/D |
67,000 |
67,000 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Chief Financial Officer |
• – – |
2006-10-24 |
4 |
S |
$35.00 |
$770,735 |
D/D |
(22,021) |
41,733 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Chief Financial Officer |
• – – |
2007-06-01 |
4 |
S |
$36.73 |
$736,446 |
D/D |
(20,000) |
19,943 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Chief Financial Officer |
• – – |
2007-06-01 |
4 |
OE |
$34.62 |
$692,400 |
D/D |
20,000 |
39,943 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Chief Financial Officer |
• – – |
2007-05-03 |
4 |
OE |
$21.19 |
$598,596 |
D/D |
28,249 |
56,249 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Chief Financial Officer |
• – – |
2005-07-21 |
4 |
S |
$59.24 |
$590,191 |
D/D |
(9,940) |
23,590 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
Chief Financial Officer |
• – – |
2007-02-09 |
4 |
S |
$34.15 |
$582,320 |
D/D |
(17,000) |
41,733 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Chief Financial Officer |
• – – |
2007-05-08 |
4 |
S |
$34.44 |
$576,974 |
D/D |
(16,751) |
28,000 |
0 |
- |
|
| WAT |
Waters Corp |
Director |
• • – |
2021-08-16 |
4 |
S |
$408.99 |
$515,327 |
D/D |
(1,260) |
1,797 |
0 |
% |
|
| WAT |
Waters Corp |
Director |
• • – |
2021-05-13 |
4 |
S |
$314.99 |
$393,423 |
D/D |
(1,249) |
1,797 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
